|
Re: Diving into....
|
6
|
Resverlogix Corp.
|
Sep 28, 2019 09:37AM
|
|
Added some on the NR
|
6
|
Resverlogix Corp.
|
Jun 14, 2018 03:26PM
|
|
Added due to participants
|
6
|
Resverlogix Corp.
|
Jun 20, 2017 11:42AM
|
|
Re: Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017
|
6
|
Resverlogix Corp.
|
Jul 25, 2017 07:09PM
|
|
RVX & Esperion
|
6
|
Resverlogix Corp.
|
Mar 20, 2017 10:35PM
|
|
Re: Estimated Glomerular Filtration Rate
|
6
|
Resverlogix Corp.
|
Nov 17, 2019 06:27PM
|
|
Re: Richmond Club presentation
|
6
|
Resverlogix Corp.
|
Mar 30, 2016 08:38PM
|
|
Re: It seems ...
|
6
|
Resverlogix Corp.
|
Nov 09, 2015 04:25PM
|
|
Re: Heavier than normal trading on the OTC for RVXCF
|
6
|
Resverlogix Corp.
|
Mar 16, 2017 02:56PM
|
|
Re: Nasdaq listing -- Awesome News!!
|
6
|
Resverlogix Corp.
|
Jul 31, 2018 05:54PM
|
|
Re: Zenith Payoff of Citi?
|
6
|
Resverlogix Corp.
|
Apr 05, 2017 05:26PM
|
|
New presentation
|
6
|
Resverlogix Corp.
|
Mar 21, 2017 11:43AM
|
|
A few thoughts
|
6
|
Resverlogix Corp.
|
Nov 16, 2019 12:52PM
|
|
Re: Could BETonMACE succeed and the FDA still deny approval?
|
6
|
Resverlogix Corp.
|
Sep 15, 2017 07:43AM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
6
|
Resverlogix Corp.
|
Sep 30, 2019 10:20AM
|
|
Re: Resverlogix Special Meeting Jun 30 9am MDT
|
6
|
Resverlogix Corp.
|
Jun 30, 2015 04:25PM
|
|
Re: BETonMACE Placebo Estimate
|
6
|
Resverlogix Corp.
|
Feb 20, 2019 08:57AM
|
|
ESPR results
|
6
|
Resverlogix Corp.
|
Aug 25, 2018 11:55AM
|
|
Re: Thoughts on PX: Calm down
|
6
|
Resverlogix Corp.
|
Mar 15, 2019 01:45PM
|
|
Vitamin D and Omega 3 don’t preserve renal fxn in Type 2 DM
|
5
|
Resverlogix Corp.
|
Nov 12, 2019 07:35AM
|
